Evaluation of a New Self-assessed, Home-based Symptom Score in Cat Allergic Patients
NCT02959073 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2017-05-03
Summary
In the last decades the prevalence of allergies has reached epidemic proportions. 10 to 15% of the population suffers from cat allergy. Investigators perform this study in order to further investigate symptom records and their evaluation in cat allergic patients.
Investigators primarily aim to better standardize the symptom recording of cat allergic persons under real-life conditions and to evaluate the effect of hypoallergenic cats on symptom strength.
Conditions
- Cat Allergy
Interventions
- OTHER
-
Symptom Recording
Subjects muss record their allergic symptoms after contact with their cats
Sponsors & Collaborators
-
Ottawa Allery Research Corporation
collaborator UNKNOWN -
University of Zurich
lead OTHER
Principal Investigators
-
Gabriela Senti Senti, Prof. Dr. · Hypo Pet AG, c/o University of Zurich
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-09-30
- Primary Completion
- 2017-02-28
- Completion
- 2017-02-28
Countries
- Canada
Study Locations
More Related Trials
-
Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma
NCT06960382 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study on the Efficacy of Environmental Probiotics in Patients With Cat Hair Allergies
NCT07114133 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
The Effect of Nasal Carbon Dioxide (CO2) on Nasal Congestion in Subjects With Perennial Allergic Rhinitis
NCT00638755 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Nasal Mucosal Permeability in Controls and House Dust Mite Allergic Rhinitis Patients
NCT02461797 ·Status: COMPLETED ·Phase: NA
-
Repeat Dose Nasal Allergen Challenge
NCT01110837 ·Status: UNKNOWN ·Phase: NA
-
Effect of Intranasal Anti-IgE Antibodies on IgE Production
NCT03019237 ·Status: COMPLETED ·Phase: NA
-
Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes.
NCT02230475 ·Status: COMPLETED
-
Validation of a Combined Symptom and Medication Score in Patients Suffering From Allergic Rhinoconjunctivitis
NCT04071249 ·Status: COMPLETED
-
Genetics of the Early and Late Response to Allergen Challenge
NCT01113697 ·Status: COMPLETED
-
International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis
NCT02041624 ·Status: TERMINATED
-
Identification of Allergic Asthmatics Reactive to Felis Catus (Cat Hair) Allergen Inhalation
NCT03780387 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Allergenic Extract Standardized Cat Hair AP in an Allergic Rhinitis Model.
NCT06828484 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Validation of an Allergic Rhinitis Control Test in Children
NCT03075917 ·Status: RECRUITING ·Phase: NA
-
Study of a Topical Nasal Spray to Ease the Symptoms of Hayfever
NCT01500629 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study in Cat-Allergic Patients With Asthma to Evaluate the Efficacy of a Single Dose of REGN1908-1909 to Reduce Bronchoconstriction Upon Cat Allergen Challenge
NCT03838731 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of 2LALERG (Homeopathic Drug) in Allergic Rhinitis Related to Grass Pollen
NCT02690935 ·Status: COMPLETED ·Phase: PHASE4
-
Biomarkers in Nasal Samples of Seasonal Allergic Rhinitics
NCT04670627 ·Status: COMPLETED
-
Monitoring Allergen Immunotherapy in Allergic Rhinitis
NCT05621356 ·Status: UNKNOWN
-
Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite Allergen
NCT01936818 ·Status: COMPLETED
-
Exposure Chamber Trial With Cat Immunotherapy
NCT00987909 ·Status: COMPLETED ·Phase: PHASE2
-
Integrative Omics Approach to Allergic Rhinitis
NCT03324100 ·Status: ACTIVE_NOT_RECRUITING
-
Mediators in Nasal Hyperreactivity in Allergic Rhinitis and Chronic Rhinosinusitis
NCT04286542 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis
NCT00263549 ·Status: COMPLETED ·Phase: PHASE4
-
Nasal Allergen Challenge in Rhinitic Subjects
NCT01286129 ·Status: COMPLETED ·Phase: NA
-
Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis
NCT06577077 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3